PDS Biotechnology Stock Options
| PDSB Stock | USD 2.65 0.25 8.62% |
PDS Biotechnology's option chain provides insight into all available option contracts written on PDS Biotechnology's stock. Investors can see outstanding put and call contracts with pricing information and greeks for a given expiration period. In addition, each of PDS Biotechnology's stock options below provides a detailed picture of the payoff. Comparing vital and dynamic information of various option contracts across diverse expiration periods will help you make an educated decision on your market timing strategies around investing in a given PDS option contract.
In The Money vs. Out of Money Option Contracts on PDS Biotechnology
Analyzing PDS Biotechnology's in-the-money options over time can help investors to take a profitable long position in PDS Biotechnology regardless of its overall volatility. This is especially true when PDS Biotechnology's options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money PDS Biotechnology's options could be used as guardians of the underlying stock as they move almost dollar for dollar with PDS Biotechnology's stock while costing only a fraction of its price.
PDS Biotechnology's latest option contracts expiring on 2024-04-19 are carrying combined implied volatility of 0.0 with a put-to-call open interest ratio of 0.13 over 10 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on 2024-04-19. The current put volume is at 0, with calls trading at the volume of 35. This yields a 0.0 put-to-call volume ratio. The PDS Biotechnology option chain provides detailed quote and price information for the current PDS Biotechnology Corp option contracts. It shows all of PDS Biotechnology's listed puts, calls, expiration dates, strike prices, and other pricing information.
Open Interest Against 2024-04-19 Option Contracts
PDS Biotechnology option prices can potentially be used to forecast stock returns because most option chains provide information not only about the current prices but also about the future conditions in PDS Biotechnology's lending market. For example, when PDS Biotechnology's puts are not actively trading or completely missing in the marketplace, investors can use it to internalize expected shorting costs. So if an investor is writing a put option on PDS Biotechnology, he or she must hedge the risk by shorting PDS Biotechnology stock over its option's life.
2024-04-19
The chart above shows PDS Biotechnology's distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. PDS Biotechnology's open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for PDS Biotechnology's option, there is no secondary market available for investors to trade.
PDS Biotechnology's stock options are financial instruments that give investors the right to buy or sell shares of PDS Biotechnology Corp common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell PDS stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If PDS Biotechnology's stock price goes up or down, the stock options follow.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PDS Biotechnology Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state. Please note that buying 'in-the-money' options on PDS Biotechnology lessens the impact of time decay, as they carry both intrinsic and time value. So, even if PDS Biotechnology's value remains static through the expiration date, the investor can sell to close an 'in-the-money' option to avoid a potential loss. However, in-the-money PDS Biotechnology contracts are usually more expensive to enter than their out-of-the-money counterparts. So keep in mind that while the payoffs on an in-the-money trade can be high, the investors could ultimately experience a more consequential loss if PDS Stock moves the wrong way.
At present, PDS Biotechnology's Total Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Common Stock Shares Outstanding is expected to grow to about 32.5 M, whereas Common Stock Total Equity is forecasted to decline to 7,462. PDS Current Options Market Mood
PDS Biotechnology's open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps PDS Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
Most options investors, including buyers and sellers of PDS Biotechnology's calls and puts, are not very successful. It is estimated that an average options trader loses somewhere between 80% to 90% of the time. PDS Biotechnology's option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction. Using current PDS Biotechnology's option volume and open interest to make an investment decision is considered a contrarian-sentiment measure that can be utilized in many timing strategies in both derivative and spot marketplace.
Rule 16 of the current PDS contract
Base on the Rule 16, the options market is currently suggesting that PDS Biotechnology Corp will have an average daily up or down price movement of about 0.0% per day over the life of the 2024-04-19 option contract. With PDS Biotechnology trading at USD 2.65, that is roughly USD 0.0. If you think that the market is fully incorporating PDS Biotechnology's daily price movement you should consider buying PDS Biotechnology Corp options at the current volatility level of 0.0%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
PDS |
Purchasing PDS Biotechnology options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" PDS calls. Remember, the seller must deliver PDS Biotechnology Corp stock to the call owner when a call is exercised.
PDS Biotechnology Total Stockholder Equity Over Time
The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders. Total Stockholder Equity |
| Timeline |
PDS Biotechnology Common Stock Total Equity Over Time
The total value of common stock equity held by shareholders, representing their ownership interest in the company. Common Stock Total Equity |
| Timeline |
PDS Total Stockholder Equity
Total Stockholder Equity |
|
Be your own money manager
Our tools can tell you how much better you can do entering a position in PDS Biotechnology without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Piotroski F Score Now
Piotroski F ScoreGet Piotroski F Score based on the binary analysis strategy of nine different fundamentals |
| All Next | Launch Module |
PDS Biotechnology Corporate Directors
PDS Biotechnology corporate directors refer to members of a PDS Biotechnology board of directors. The board of directors generally takes responsibility for the PDS Biotechnology's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of PDS Biotechnology's board members must vote for the resolution. The PDS Biotechnology board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| James Loughlin | Independent Director | Profile | |
| Stephen Glover | Independent Director | Profile | |
| Richard Sykes | Director | Profile | |
| Gregory Freitag | Director | Profile |
Already Invested in PDS Biotechnology Corp?
The danger of trading PDS Biotechnology Corp is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of PDS Biotechnology is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than PDS Biotechnology. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile PDS Biotechnology Corp is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether PDS Biotechnology Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of PDS Biotechnology's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Pds Biotechnology Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Pds Biotechnology Corp Stock: Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PDS Biotechnology Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Complementary Tools for PDS Stock analysis
When running PDS Biotechnology's price analysis, check to measure PDS Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PDS Biotechnology is operating at the current time. Most of PDS Biotechnology's value examination focuses on studying past and present price action to predict the probability of PDS Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PDS Biotechnology's price. Additionally, you may evaluate how the addition of PDS Biotechnology to your portfolios can decrease your overall portfolio volatility.
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |
Is PDS Biotechnology's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of PDS Biotechnology. If investors know PDS will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about PDS Biotechnology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.39) | Return On Assets (0.39) | Return On Equity (1.22) |
The market value of PDS Biotechnology Corp is measured differently than its book value, which is the value of PDS that is recorded on the company's balance sheet. Investors also form their own opinion of PDS Biotechnology's value that differs from its market value or its book value, called intrinsic value, which is PDS Biotechnology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because PDS Biotechnology's market value can be influenced by many factors that don't directly affect PDS Biotechnology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between PDS Biotechnology's value and its price as these two are different measures arrived at by different means. Investors typically determine if PDS Biotechnology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, PDS Biotechnology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.